XML 21 R5.htm IDEA: XBRL DOCUMENT v3.21.2
STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2019 $ 355,000 $ 177 $ 2,713,087 $ (5,252,701) $ (2,184,437)
Beginning balance (in shares) at Dec. 31, 2019 500,000 17,900,639      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued in conjunction with vendor settlement     7,352   7,352
Shares issued in conjunction with vendor settlement (in shares)   10,355      
Shares issued for consulting services   $ 6 289,994   290,000
Shares issued for consulting services (in shares)   600,000      
Stock-based compensation     5,265   5,265
Net loss       (451,241) (451,241)
Ending balance at Mar. 31, 2020 $ 355,000 $ 183 3,015,698 (5,703,942) (2,333,061)
Ending balance (in shares) at Mar. 31, 2020 500,000 18,510,994      
Beginning balance at Dec. 31, 2019 $ 355,000 $ 177 2,713,087 (5,252,701) (2,184,437)
Beginning balance (in shares) at Dec. 31, 2019 500,000 17,900,639      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (3,461,479)
Ending balance at Sep. 30, 2020 $ 355,000 $ 286 7,474,723 (8,714,180) (884,171)
Ending balance (in shares) at Sep. 30, 2020 500,000 28,810,348      
Beginning balance at Mar. 31, 2020 $ 355,000 $ 183 3,015,698 (5,703,942) (2,333,061)
Beginning balance (in shares) at Mar. 31, 2020 500,000 18,510,994      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued in conjunction with convertible promissory note   $ 1 42,968   42,969
Shares issued in conjunction with convertible promissory note (in shares)   100,000      
Beneficial conversion feature in conjunction with convertible promissory note     8,800   8,800
Issuance of common stock for cash   $ 1 49,999   50,000
Issuance of common stock for cash (in shares)   142,857      
Shares issued for consulting services   $ 20 599,980   600,000
Shares issued for consulting services (in shares)   2,000,000      
Warrant issued for services     37,149   37,149
Warrant issued in conjunction with convertible promissory note     48,231   48,231
Stock-based compensation     5,481   5,481
Net loss       (840,255) (840,255)
Ending balance at Jun. 30, 2020 $ 355,000 $ 205 3,808,306 (6,544,197) (2,380,686)
Ending balance (in shares) at Jun. 30, 2020 500,000 20,753,851      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Beneficial conversion feature in conjunction with convertible promissory note     390,000   390,000
Shares issued for consulting services   $ 9 1,817,991   1,818,000
Shares issued for consulting services (in shares)   900,000      
Conversion of KISS liability- related party shares   $ 72 1,452,473   1,452,545
Conversion of KISS liability- related party shares (in shares)   7,156,497      
Stock-based compensation     5,953   5,953
Net loss       (2,169,983) (2,169,983)
Ending balance at Sep. 30, 2020 $ 355,000 $ 286 7,474,723 (8,714,180) (884,171)
Ending balance (in shares) at Sep. 30, 2020 500,000 28,810,348      
Beginning balance at Dec. 31, 2020 $ 355,000 $ 269 7,957,860 (9,631,732) (1,318,603)
Beginning balance (in shares) at Dec. 31, 2020 500,000 27,175,800      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrants issued in conjunction with convertible promissory notes     420,096   420,096
Warrants reset in conjunction with convertible promissory notes (Restated)     510,222 (510,222)  
Conversion of convertible promissory note   $ 10 380,093   380,103
Conversion of convertible promissory note (in shares)   1,019,113      
Shares issued for consulting services   $ 11 693,815   693,826
Shares issued for consulting services (in shares)   1,084,120      
Stock-based compensation   $ 11 604,890   604,901
Stock-based compensation (in shares)   1,100,000      
Net loss       (2,560,384) (2,560,384)
Ending balance at Mar. 31, 2021 $ 355,000 $ 301 10,566,976 (12,702,338) (1,780,061)
Ending balance (in shares) at Mar. 31, 2021 500,000 30,379,033      
Beginning balance at Dec. 31, 2020 $ 355,000 $ 269 7,957,860 (9,631,732) (1,318,603)
Beginning balance (in shares) at Dec. 31, 2020 500,000 27,175,800      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of convertible note and note payable         $ 1,549,800
Conversion of convertible note and note payable (in shares)         43,316,791
Net loss         $ (6,634,722)
Ending balance at Sep. 30, 2021 $ 355,000 $ 747 17,828,794 (20,015,149) (1,830,608)
Ending balance (in shares) at Sep. 30, 2021 500,000 74,926,711      
Beginning balance at Mar. 31, 2021 $ 355,000 $ 301 10,566,976 (12,702,338) (1,780,061)
Beginning balance (in shares) at Mar. 31, 2021 500,000 30,379,033      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrants reset in conjunction with convertible promissory notes (Restated)     3,230,077 (3,230,077)  
Conversion of convertible promissory note   $ 122 974,192   974,314
Conversion of convertible promissory note (in shares)   12,161,575      
Shares issued for consulting services   $ 13 110,387   110,400
Shares issued for consulting services (in shares)   1,250,000      
Net loss       (774,532) (774,532)
Ending balance at Jun. 30, 2021 $ 355,000 $ 436 14,881,632 (16,706,947) (1,469,879)
Ending balance (in shares) at Jun. 30, 2021 500,000 43,790,608      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Warrants reset in conjunction with convertible promissory notes (Restated)     8,396 (8,396)  
Conversion of convertible promissory note   $ 301 2,938,776   2,939,077
Conversion of convertible promissory note (in shares)   30,136,103      
Shares issued in conjunction with warrant cancellation   $ 10 (10)    
Shares issued in conjunction with warrant cancellation (in shares)   1,000,000      
Net loss       (3,299,806) (3,299,806)
Ending balance at Sep. 30, 2021 $ 355,000 $ 747 $ 17,828,794 $ (20,015,149) $ (1,830,608)
Ending balance (in shares) at Sep. 30, 2021 500,000 74,926,711